Radiation Sensitization of HNSCC Cells by the dual PI3K / mTOR Inhibitor BEZ235 as a function of the Cell Cycle

被引：0
|
作者：
Brandt, F. W. [1 ]
Balzer, V [1 ]
Dreffke, K. [1 ]
Wittig, A. [1 ,2 ]
Dikomey, E. [1 ,3 ]
Arenz, A. [1 ]
Schoetz, U. [1 ]
Engenhart-Cabillic, R. [1 ]
机构：
[1] Philipps Univ Marburg, Klin Strahlentherapie & Radioonkol, Marburg, Germany
[2] Univ Klinikum Jena, Klin Strahlentherapie & Radioonkol, Jena, Germany
[3] UKE Hamburg, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P19-3-jD
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [31] The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma
    Wu, Ning
    Zhu, Yingfeng
    Xu, Xiao
    Zhu, Yongjun
    Song, Yang
    Pang, Liewen
    Chen, Zhiming
    JOURNAL OF CANCER, 2018, 9 (06): : 987 - 997
  • [32] The PI3K/mTOR inhibitor BEZ235 given twice daily for the treatment of patients (pts) with advanced solid tumors
    Arkenau, Hendrik-Tobias
    Jones, Suzanne Fields
    Kurkjian, Carla
    Infante, Jeffrey R.
    Pant, Shubham
    Burris, Howard A.
    Moore, Kathleen N.
    McMeekin, D. Scott
    Greco, Frank A.
    Ramsey, Sara
    Bendell, Johanna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
    Serra, Violeta
    Markman, Ben
    Scaltriti, Maurizio
    Eichhorn, Pieter J. A.
    Valero, Vanesa
    Guzman, Marta
    Luisa Botero, Maria
    Llonch, Elisabeth
    Atzori, Francesco
    Di Cosimo, Serena
    Maira, Michel
    Garcia-Echeverria, Carlos
    Lluis Parra, Josep
    Arribas, Joaquin
    Baselga, Jose
    CANCER RESEARCH, 2008, 68 (19) : 8022 - 8030
  • [34] Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines
    Subtil, Florentine S. B.
    Groebner, Carolin
    Recknagel, Niklas
    Parplys, Ann Christin
    Kohl, Sibylla
    Arenz, Andrea
    Eberle, Fabian
    Dikomey, Ekkehard
    Engenhart-Cabillic, Rita
    Schoetz, Ulrike
    CANCERS, 2022, 14 (13)
  • [35] BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway
    Li, Amin
    Zhang, Rongbo
    Zhang, Yinci
    Liu, Xueke
    Wang, Ruikai
    Liu, Jiachang
    Liu, Xinkuang
    Xie, Yinghai
    Cao, Weiya
    Xu, Ruyue
    Ma, Yongfang
    Cai, Wenpeng
    Wu, Binquan
    Cai, Shuyu
    Tang, Xiaolong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 5573 - 5585
  • [36] Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models
    Ma, Brigette B. Y.
    Lui, Vivian W. Y.
    Hui, Connie W. C.
    Lau, Cecilia P. Y.
    Wong, Chi H.
    Hui, Edwin P.
    Ng, Margaret H. L.
    Cheng, Suk H.
    Tsao, Sai W.
    Tsang, Chi-Man
    Cheung, Crystal S. F.
    Ho, Kakiu
    Chan, Anthony T. C.
    CANCER LETTERS, 2014, 343 (01) : 24 - 32
  • [37] PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
    Chen, Liyan
    Jin, Tiefeng
    Zhu, Kun
    Piao, Yingshi
    Quan, Taihao
    Quan, Chunji
    Lin, Zhenhua
    ONCOTARGET, 2017, 8 (07) : 11937 - 11949
  • [38] RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway
    Xiaolong Tang
    Amin Li
    Chunmei Xie
    Yinci Zhang
    Xueke Liu
    Yinghai Xie
    Binquan Wu
    Shuping Zhou
    Xudong Huang
    Yongfang Ma
    Weiya Cao
    Ruyue Xu
    Jing Shen
    Zhen Huo
    Shuyu Cai
    Yong Liang
    Dong Ma
    Nanoscale Research Letters, 15
  • [39] A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
    Wei, Xiao X.
    Hsieh, Andrew C.
    Kim, Won
    Friedlander, Terence
    Lin, Amy M.
    Louttit, Mirela
    Ryan, Charles J.
    ONCOLOGIST, 2017, 22 (05): : 503 - +
  • [40] Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions (vol 106, pg 138, 2013)
    Potiron, Vincent A.
    Abderrahmani, Rym
    Giang, Eric
    Chiavassa, Sophie
    Di Tomaso, Emmanuelle
    Maira, Sauveur-Michel
    Paris, Francois
    Supiot, Stephane
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (02) : 263 - 263
12345